Table 1.
Clinical characteristics between groups with/without aICAS.
| Variable | Without aICAS | With aICAS | P-value |
|---|---|---|---|
| N (%) | 4,619 (86.9) | 695 (13.1) | |
| Age, years | 51.72 (45.36–59.91) | 59.00 (49.91–72.48) | <0.001 |
| Male, n (%) | 2,750 (59.5) | 443 (63.7) | 0.035 |
| High school or above, n (%) | 2,046 (44.3) | 262 (31.7) | 0.001 |
| Income >1,000 RMB/m, n (%) | 3,617 (78.3) | 561 (80.7) | 0.148 |
| BMI, kg/m2 | 24.72 (22.65–26.99) | 24.77 (22.86–27.34) | 0.355 |
| Systolic blood pressure, mm Hg | 130.0 (118.7–140.0) | 140.0 (130.0–156.7) | <0.001 |
| Diastolic blood pressure, mm Hg | 80.67 (76.67–90.00) | 80.67 (76.67–90.00) | 0.061 |
| Current smoker, n (%) | 1,481 (32.1) | 220 (32.0) | 0.830 |
| Current alcohol use, n (%) | 672 (14.6) | 82 (11.8) | 0.053 |
| Active physical activity, n (%) | 2,753 (59.6) | 2,753 (59.6) | 0.226 |
| Diabetes, n (%) | 484 (10.5) | 149 (21.4) | <0.001 |
| Hypertension, n (%) | 2,065 (44.7) | 475 (60.4) | <0.001 |
| Dyslipidemia, n (%) | 2,176 (47.1) | 372 (53.5) | 0.002 |
| Antihypertensive agents, n (%) | 752 (16.3) | 256 (36.8) | <0.001 |
| Antidiabetic agents, n (%) | 227 (4.9) | 85 (12.2) | <0.001 |
| FBG, mmol/L | 5.20 (4.81–5.72) | 5.40 (4.89–6.22) | <0.001 |
| TC, mmol/L | 4.91 (4.33–5.59) | 5.17 (4.51–5.81) | <0.001 |
| TG, mmol/L | 1.29 (0.92–1.92) | 1.32 (0.98–1.92) | 0.167 |
| HDL-C, mmol/L | 1.57 (1.31–1.90) | 1.32 (0.98–1.85) | 0.051 |
| LDL-C, mmol/L | 2.59 (2.16–3.04) | 2.70 (2.21–3.15) | 0.002 |
| Non-HDL-C, mmol/L | 3.29 (2.74–3.97) | 3.63 (2.96–4.25) | <0.001 |
| TG/HDL-C | 0.83 (0.54–1.31) | 0.88 (0.58–1.34) | 0.054 |
| AC | 2.09 (1.60–2.78) | 2.37 (1.76–3.04) | <0.001 |
| AIP | −0.19 (−0.61–0.27) | −0.13 (−0.54–0.29) | 0.054 |
| CRI-I | 3.09 (2.60–3.97) | 3.37 (2.76–4.04) | <0.001 |
| CRI-II | 1.63 (1.28–2.04) | 1.73 (1.35–2.19) | <0.001 |